HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study

NCT ID: NCT03055130

Last Updated: 2017-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-07-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The associations between female inflammatory bowel disease (IBD) patients and human papilloma virus (HPV) infection and cervical neoplasia (dysplasia or cancer) were unclear. Especially there was no data for Chinese IBD population. So we investigated the incidence and risk factors of HPV infection and cervical neoplasia (dysplasia or cancer) in female IBD patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HPV-Related Cervical Carcinoma Inflammatory Bowel Diseases Cervical Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case group

Female IBD patients who had sexual life between 21-60 years-old were recruited.

Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist

Intervention Type OTHER

control group

Female people who perform physical examination in our hospital between 21-60 years-old were recruited as control during the study period.

Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. between 20-60 years old;
2. Patients diagnosed as IBD according to previously established international criteria

Exclusion Criteria

1\. Patients refuse to participating
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiang Gao

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiang Gao, PhD

Role: STUDY_DIRECTOR

The sixth affiated hospital of Sun-Yat sen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Gastroenterology

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Qingfan Yang, MD

Role: CONTACT

+860203866343

Xiang Gao, PhD

Role: CONTACT

+860203866343

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qingfan Yang, MM

Role: primary

+8613450399302

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HHBY-YJFA-20160813

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.